Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection

Infection and Immunity

Volumn 68, Issue 1, 2000, Pages 87-92

  Laine, V Jukka O ^a   Grass, David S ^b   Nevalainen, Timo J ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Chrysalis DNX Transgenic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CATALYSIS; CONTROLLED STUDY; ESCHERICHIA COLI; HOST RESISTANCE; INFECTION RESISTANCE; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM BACTERICIDAL ACTIVITY; STAPHYLOCOCCUS AUREUS; TRANSGENIC MOUSE;

EID: 0033966028     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.1.87-92.2000     Document Type: Article

References (33)

1. Anderson, B. O., E. E. Moore, and A. Banerjee. 1994. Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure. J. Surg. Res. 56:199-205.
2. Asaoka, Y., K. Yoshida, Y. Sasaki, Y. Nishizuka, M. Murakami, I. Kudo, and K. Inoue. 1993. Possible role of mammalian secretory group II phospholipase A2 in T-lymphocyte activation: implication in propagation of inflammatory reaction. Proc. Natl. Acad. Sci. USA 90:715-719.
3. Crowl, R. M., T. J. Stoller, R. R. Conroy, and C. R. Stoner. 1991. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 266:2647-2651.
4. Dennis, E. A. 1997. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1-2.
5. Grass, D. S., R. H. Felkner, M. Y. Chiang, R. E. Wallace, T. J. Nevalainen, C. F. Bennett, and M. E. Swanson. 1996. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Investig. 97:2233-2241.
6. Green, J. A., G. M. Smith, R. Buchta, R. Lee, K. Y. Ho, I. A. Rajkovic, and K. F. Scott. 1991. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation 15:355-367.
7. Grönroos, J. M., K. Kuttila, and T. J. Nevalainen. 1994. Group II phospholipase A2 in serum in critically ill surgical patients. Crit. Care Med. 22:956-959.
8. Guidet, B., O. Piot, J. Masliah, V. Barakett, E. Maury, G. Bereziat, and G. Offfenstadt. 1996. Secretory non-pancreatic phospholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2. Infection 24:103-108.
9. Hara, S., I. Kudo, H. W. Chang, K. Matsuta, T. Miyamoto, and K. Inoue. 1989. Purification and characterization of extracellular phospholipase A2 from human synovial fluid in rheumatoid arthritis. J. Biochem. (Tokyo) 105:395-399.
10. Jacobson, P. B., and D. J. Schrier. 1993. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2. J. Immunol. 151:5639-5652.
11. Kallajoki, M., and T. J. Nevalainen. 1997. Expression of group II phospholipase A2 in human tissues, p. 8-16. In W. Uhl, T. J. Nevalainen, and M. W. Büchler (ed.), Phospholipase A2. Basic and clinical aspects in inflammatory diseases, vol. 24. Karger AG, Basel, Switzerland.
12. Kennedy, B. P., P. Payette, J. Mudgett, P. Vadas, W. Pruzanski, M. Kwan, C. Tang, D. E. Rancourt, and W. A. Cromlish. 1995. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J. Biol. Chem. 270:22378-22385.
13. Keuter, M., E. Dharmana, B. J. Kullberg, C. Schalkwijk, M. H. Gasem, L. Seuren, R. Djokomoeljanto, W. M. Dolmans, H. van den Bosch, and J. W. van der Meer. 1995. Phospholipase A2 is a circulating mediator in typhoid fever. J. Infect. Dis. 172:305-308.
14. Kortekangas, P., H. T. Aro, and T. J. Nevalainen. 1994. Group II phospholipase A2 in synovial fluid and serum in acute arthritis. Scand. J. Rheumatol. 23:68-72.
15. Kramer, R. M., C. Hession, B. Johansen, G. Hayes, P. McGray, E. P. Chow, R. Tizard, and R. B. Pepinsky. 1989. Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264:5768-5775.
16. Laine, V. J. O., D. S. Grass, and T. J. Nevalainen. 1999. Protection by group II phospholipase A2 against S. aureus. J. Immunol. 162:7402-7408.
17. Laine, V. J. O., J. M. Grönroos, and T. J. Nevalainen. 1996. Serum phospholipase A2 in patients after splenectomy. Eur. J. Clin. Chem. Clin. Biochem. 34:419-422.
18. Laine, V. J. O., K. M. Nyman, H. J. Peuravuori, K. Henriksen, M. Parvinen, and T. J. Nevalainen. 1996. Lipopolysaccharide induced apoptosis of rat pancreatic acinar cells. Gut 38:747-752.
19. Madsen, L. M., M. Inada, and J. Weiss. 1996. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli. Infect. Immun. 64:2425-2430.
20. Nevalainen, T. J. 1993. Serum phospholipases A2 in inflammatory diseases. Clin. Chem. 39:2453-2459.
21. Nevalainen, T. J., J. M. Grönroos, and P. T. Kortesuo. 1993. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut 34:1133-1136.
22. Nevalainen, T. J., M. Kallajoki, E. Pesonen, S. Andersson, P. Kärkkäinen, and K. Höckerstedt. 1996. Origin of circulating group II phospholipase A2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab. Investig. 74:585-591.
23. Nevalainen, T. J., P. T. Kortesuo, E. Rintala, and F. Märki. 1992. Immunochemical detection of group I and group II phospholipases A2 in human serum. Clin. Chem. 38:1824-1829.
24. Nevalainen, T. J., V. J. O. Laine, and D. S. Grass. 1997. Expression of human group II phospholipase A2 in transgenic mice. J. Histochem. Cytochem. 45:1109-1119.
25. Nyman, K. M., W. Uhl, J. Forsström, M. Büchler, H. G. Beger, and T. J. Nevalainen. 1996. Serum phospholipase A2 in patients with multiple organ failure. J. Surg. Res. 60:7-14.
26. Ogawa, M., H. Arakawa, S. Yamashita, K. Sakamoto, and S. Ikei. 1992. Postoperative elevations of serum interleukin 6 and group II phospholipase A2: group II phospholipase A2 in serum is an acute phase reactant. Res. Commun. Chem. Pathol. Pharmacol. 75:109-115.
27. Pruzanski, W., D. W. Wilmore, A. Suffredini, G. D. Martich, A. G. Hoffman, J. L. Browning, E. Stefanski, B. Sternby, and P. Vadas. 1992. Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin. Inflammation 16:561-570.
28. Qu, X. D., and R. I. Lehrer. 1998. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Neurochem. Res. 23:807-814.
29. Rintala, E. M., and T. J. Nevalainen. 1993. Group II phospholipase A2 in sera of febrile patients with microbiologically or clinically documented infections. Clin. Infect. Dis. 17:864-870.
30. Vadas, P., W. Pruzanski, E. Stefanski, L. G. Ellies, J. E. Aubin, A. Sos, and A. Melcher. 1991. Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action. Immunol. Lett. 28:187-193.
31. Weinrauch, Y., C. Abad, N.-S. Liang, S. F. Lowry, and J. Weiss. 1998. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. J. Clin. Investig. 102:633-638.
32. Weinrauch, Y., P. Elsbach, L. M. Madsen, A. Foreman, and J. Weiss. 1996. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J. Clin. Investig. 97:250-257.
33. Weiss, J., M. Inada, P. Elsbach, and R. M. Crowl. 1994. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J. Biol. Chem. 269:26331-26337.